Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells?
- PMID: 14989265
- DOI: 10.1016/j.abb.2003.12.022
Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells?
Abstract
The most commonly measured marker of oxidative DNA damage is 8-oxo-7,8-dihydroguanine (8-oxoGua) or its deoxyribonucleoside (8-oxodGuo). Published estimates of the concentration of 8-oxoGua/8-oxodGuo in DNA of normal human cells vary over a range of three orders of magnitude. Analysis by chromatographic methods (GC-MS, HPLC with electrochemical detection (ECD) or HPLC-MS/MS) is beset by the problem of adventitious oxidation of guanine during sample preparation. An alternative approach, based on the use of the DNA repair enzyme formamidopyrimidine DNA N-glycosylase (FPG) to make breaks in the DNA at sites of the oxidised base, gives much lower values. ESCODD, the European Standards Committee on Oxidative DNA Damage, has been testing the ability of different laboratories using a variety of methods to measure 8-oxoGua in standard samples of 8-oxodGuo, calf thymus DNA, pig liver, oligonucleotides, and HeLa cells, and in lymphocytes isolated from blood of volunteers. HPLC-ECD is capable of measuring 8-oxodGuo induced experimentally in calf thymus DNA or HeLa cells with high accuracy. However, there is no sign of consensus over the background level of this damage, suggesting that, even though standard extraction procedures were used, variable oxidation of Gua is still occurring. GC-MS failed to detect a dose response of induced 8-oxoGua and cannot be regarded as a reliable method for measuring low levels of damage. HPLC-MS/MS as yet has not proved capable of measuring low levels of oxidative DNA damage. FPG-based methods seem to be less prone to the artefact of additional oxidation. Although they can be used quantitatively, they require careful calibration and standardisation if they are to be used in human biomonitoring. The background level of DNA oxidation in normal human cells is likely to be around 0.3-4.2 8-oxoGua per 10(6) Gua. An effort should be made to develop alternative, validated methods for estimating oxidative DNA damage.
Similar articles
-
Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study.FASEB J. 2005 Jan;19(1):82-4. doi: 10.1096/fj.04-1767fje. Epub 2004 Nov 8. FASEB J. 2005. PMID: 15533950
-
Measurement of DNA oxidation in human cells by chromatographic and enzymic methods.Free Radic Biol Med. 2003 Apr 15;34(8):1089-99. doi: 10.1016/s0891-5849(03)00041-8. Free Radic Biol Med. 2003. PMID: 12684094
-
Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus.Carcinogenesis. 2002 Dec;23(12):2129-33. doi: 10.1093/carcin/23.12.2129. Carcinogenesis. 2002. PMID: 12507938
-
Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols.Am J Clin Nutr. 2005 Jan;81(1 Suppl):261S-267S. doi: 10.1093/ajcn/81.1.261S. Am J Clin Nutr. 2005. PMID: 15640489 Review.
-
Facts about the artifacts in the measurement of oxidative DNA base damage by gas chromatography-mass spectrometry.Free Radic Res. 1998 Dec;29(6):551-63. doi: 10.1080/10715769800300591. Free Radic Res. 1998. PMID: 10098459 Review.
Cited by
-
Mode of action-based risk assessment of genotoxic carcinogens.Arch Toxicol. 2020 Jun;94(6):1787-1877. doi: 10.1007/s00204-020-02733-2. Epub 2020 Jun 15. Arch Toxicol. 2020. PMID: 32542409 Free PMC article. Review.
-
Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications.DNA Res. 2016 Dec;23(6):547-559. doi: 10.1093/dnares/dsw038. Epub 2016 Jul 31. DNA Res. 2016. PMID: 27477585 Free PMC article.
-
Formation and repair of oxidatively generated damage in cellular DNA.Free Radic Biol Med. 2017 Jun;107:13-34. doi: 10.1016/j.freeradbiomed.2016.12.049. Epub 2017 Jan 2. Free Radic Biol Med. 2017. PMID: 28057600 Free PMC article. Review.
-
Acetylsalicylic Acid with Ascorbate: A Promising Combination Therapy for Solid Tumors.Drugs R D. 2024 Jun;24(2):303-316. doi: 10.1007/s40268-024-00479-1. Epub 2024 Jul 16. Drugs R D. 2024. PMID: 39012613 Free PMC article.
-
Pyrimidine base damage is increased in women with BRCA mutations.Cancer Lett. 2013 Sep 28;338(2):267-70. doi: 10.1016/j.canlet.2013.04.001. Epub 2013 Apr 11. Cancer Lett. 2013. PMID: 23583677 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous